4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-15-061770
Chief Executive Officer sold 5,200 shares at an average $60.71 ($315,680)
From the SEC's structured data for this filing
Trades in this filing
Ciechanover Isaac E. · Chief Executive Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-07-16 | Sale : show line 1 in the form | −1,710 | $60.90 | $104,139 | 388,872 | I |
| 2015-07-16 | Sale : show line 2 in the form | −690 | $61.70 | $42,573 | 388,182 | I |
| 2015-07-16 | Sale : show line 3 in the form | −200 | $62.90 | $12,580 | 387,982 | I |
| 2015-07-17 | Sale : show line 4 in the form | −1,800 | $59.90 | $107,820 | 386,182 | I |
| 2015-07-17 | Sale : show line 5 in the form | −800 | $60.71 | $48,568 | 385,382 | I |
| Open-market sales · 5,200 sh · avg $60.71 · $315,680 | ||||||
Loading xslF345X03/doc4.xml…